Health Condition 1: N158- Other specified renal tubulo-interstitial diseases
Conditions
Interventions
Intervention1: Clonidine 15 g with Hyperbaric 0.5% Bupivacaine: Intrathecal administration of 9 mg Hyperbaric 0.5% Bupivacaine combined with 30 g Clonidine, administered at L3-L4 interspace for pati
Sponsors
Datta Meghe Institute of Medical Sciences Sawangi Meghe Wardha
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged between 18 and 60 years undergoing urological surgeries. ASA (American Society of Anesthesiologists) Grade I and II patients. Patients willing to provide written informed consent. Patients of either gender who meet the study criteria.
Exclusion criteria
Exclusion criteria: Patients unwilling to participate in the study. ASA Grade III and above patients. Patients with haemorrhagic diathesis or significant scoliosis/kyphosis. Pregnant patients. Patients allergic to the test drugs (clonidine or bupivacaine). Patients with severe comorbid conditions (e.g., uncontrolled hypertension or diabetes). Patients with history of neurological or spinal disorders impacting the administration of spinal anaesthesia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Onset of sensory block to T10 level and elevation of sensory block to T6 level using pinprick method in patients undergoing urological surgeries.Timepoint: Onset of sensory block to T10 level and elevation of sensory block to T6 level using pinprick method in patients undergoing urological surgeries. | — |
Secondary
| Measure | Time frame |
|---|---|
| Onset and duration of motor and sensory blockade, duration of postoperative analgesia, and hemodynamic stability (heart rate, blood pressure, SpO2).Timepoint: Monitored continuously post-intrathecal injection and at regular intervals intraoperatively and postoperatively until discharge or the first rescue analgesia request. | — |
Countries
India
Contacts
Public ContactSheetal Madhavi
Datta Meghe Institute of Higher Education and Research
Outcome results
None listed